Page last updated: 2024-12-07

2,4-diamino-5-benzylpyrimidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,4-diamino-5-benzylpyrimidine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID81752
CHEMBL ID265493
SCHEMBL ID380792
MeSH IDM0099650

Synonyms (15)

Synonym
2,4-pyrimidinediamine, 5-(phenylmethyl)-
2,4-diamino-5-benzylpyrimidine
5-benzyl-pyrimidine-2,4-diamine
5-benzylpyrimidine-2,4-diamine
CHEMBL265493 ,
7319-45-1
A837743
bdbm50391226
5-benzyl-2,4-diaminopyrimidine
AKOS006341332
DTXSID20223436
mfcd09877845
SCHEMBL380792
SB59618
PD119577
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dihydrofolate reductaseGallus gallus (chicken)Ki19.49850.11220.21580.3311AID56467; AID56468; AID56486
Dihydrofolate reductaseLacticaseibacillus caseiKi6.30960.00001.26756.3096AID57779; AID57927
Dihydrofolate reductaseEscherichia coli K-12IC50 (µMol)2.66910.00150.55126.8000AID1146765; AID57578
Dihydrofolate reductaseEscherichia coli K-12Ki0.66070.00000.37904.0200AID57588
Dihydrofolate reductaseCandida albicansIC50 (µMol)35.12670.00220.91875.0000AID57075; AID57107; AID58100
Dihydrofolate reductase Salmonella enterica subsp. enterica serovar TyphiKi0.66070.00450.11790.6607AID57579
Dihydrofolate reductaseRattus norvegicus (Norway rat)IC50 (µMol)115.30000.00060.35076.2000AID57789
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
one-carbon metabolic processDihydrofolate reductaseGallus gallus (chicken)
response to methotrexateDihydrofolate reductaseGallus gallus (chicken)
tetrahydrofolate metabolic processDihydrofolate reductaseGallus gallus (chicken)
tetrahydrofolate biosynthetic processDihydrofolate reductaseGallus gallus (chicken)
dihydrofolate metabolic processDihydrofolate reductaseGallus gallus (chicken)
folic acid metabolic processDihydrofolate reductaseGallus gallus (chicken)
10-formyltetrahydrofolate biosynthetic processDihydrofolate reductaseEscherichia coli K-12
response to xenobiotic stimulusDihydrofolate reductaseEscherichia coli K-12
folic acid biosynthetic processDihydrofolate reductaseEscherichia coli K-12
one-carbon metabolic processDihydrofolate reductaseEscherichia coli K-12
response to methotrexateDihydrofolate reductaseEscherichia coli K-12
tetrahydrofolate biosynthetic processDihydrofolate reductaseEscherichia coli K-12
response to antibioticDihydrofolate reductaseEscherichia coli K-12
dihydrofolate metabolic processDihydrofolate reductaseEscherichia coli K-12
folic acid metabolic processDihydrofolate reductaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
mRNA bindingDihydrofolate reductaseGallus gallus (chicken)
dihydrofolate reductase activityDihydrofolate reductaseGallus gallus (chicken)
NADP bindingDihydrofolate reductaseGallus gallus (chicken)
dihydrofolate reductase activityDihydrofolate reductaseEscherichia coli K-12
protein bindingDihydrofolate reductaseEscherichia coli K-12
folic acid bindingDihydrofolate reductaseEscherichia coli K-12
oxidoreductase activityDihydrofolate reductaseEscherichia coli K-12
NADP bindingDihydrofolate reductaseEscherichia coli K-12
methotrexate bindingDihydrofolate reductaseEscherichia coli K-12
dihydrofolic acid bindingDihydrofolate reductaseEscherichia coli K-12
NADP+ bindingDihydrofolate reductaseEscherichia coli K-12
NADPH bindingDihydrofolate reductaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
mitochondrionDihydrofolate reductaseGallus gallus (chicken)
cytosolDihydrofolate reductaseEscherichia coli K-12
cytosolDihydrofolate reductaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (46)

Assay IDTitleYearJournalArticle
AID99653Inhibitory activity against murine tumor cells (L5178Y/R)1982Journal of medicinal chemistry, May, Volume: 25, Issue:5
Inhibition by 5-(substituted-benzyl)-2,4-diaminopyrimidines of murine tumor (L5178Y) cell cultures sensitive to and resistant to methotrexate. Further evidence for the sensitivity of resistant cells to hydrophobic drugs.
AID1146765Inhibition of Escherichia coli dihydrofolate reductase1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
AID57584Apparent inhibitory (log 1/Ki) activity against Escherichia coli dihydrofolate reductase1988Journal of medicinal chemistry, Feb, Volume: 31, Issue:2
Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines.
AID23498Partition coefficient (logD) (0.1 N NAOH)1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysis.
AID23499Partition coefficient (log P) was measured in aqueous phase(methanol-water, pH 8.4)1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysis.
AID56461Inhibition of chicken liver dihydrofolate reductase1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysis.
AID58100Inhibitory activity against cell free dihydrofolate reductase (DHFR) from Mycobacterium lufu2004Journal of medicinal chemistry, Jan-01, Volume: 47, Issue:1
Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
AID57789Inhibitory activity against cell free dihydrofolate reductase (DHFR) from rat2004Journal of medicinal chemistry, Jan-01, Volume: 47, Issue:1
Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
AID57588Inhibition constant against binding of Escherichia coli dihydrofolate reductase1988Journal of medicinal chemistry, Jul, Volume: 31, Issue:7
The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules.
AID57083Inhibitory activity against dihydrofolate reductase2001Journal of medicinal chemistry, Aug-16, Volume: 44, Issue:17
Adaptive neuro-fuzzy inference system: an instant and architecture-free predictor for improved QSAR studies.
AID27590Partition coefficient (logD) (aqueous phase 0.1 N HCl)1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
AID27589Partition coefficient (logD) (0.01 N NaOH)1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
AID57075Inhibitory activity against cell free dihydrofolate reductase (DHFR) from Candida albicans2004Journal of medicinal chemistry, Jan-01, Volume: 47, Issue:1
Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
AID56486Inhibition of chicken liver Dihydrofolate reductase (dihydrofolate reductase)1998Journal of medicinal chemistry, Oct-22, Volume: 41, Issue:22
Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductase.
AID56784Inhibitory activity against bovine liver dihydrofolate reductase at pH 7.2.1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A comparison of the inhibitory action of 5-(substituted-benzyl)-2,4-diaminopyrimidines on dihydrofolate reductase from chicken liver with that from bovine liver.
AID57107Inhibitory activity against cell free dihydrofolate reductase (DHFR) from Escherichia coli2004Journal of medicinal chemistry, Jan-01, Volume: 47, Issue:1
Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
AID57927Inhibition of Dihydrofolate reductase from Lactobacillus casei1998Journal of medicinal chemistry, Oct-22, Volume: 41, Issue:22
Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductase.
AID235294Selectivity index against Lactobacillus casei DHFR. 1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.
AID1146769Inhibition of rat liver dihydrofolate reductase1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
AID57574Activity against dihydrofolate reductase of Escherichia coli strain MB 14281992Journal of medicinal chemistry, Aug-21, Volume: 35, Issue:17
Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors.
AID65359Inhibition of growth of methotrexate-resistant (MB1428) strain of Escherichia coli cells.1985Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
AID57585Inhibitory activity against dihydrofolate reductase (DHFR) from Escherichia coli (expressed as log 1/Kiapp)1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-act
AID26776Compound was evaluated for the partition coefficients probably at the pH >> 7.2 at the aqueous phase 0.1 N HCl1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
AID56796Inhibition of dihydrofolate reductase from bovine liver1981Journal of medicinal chemistry, May, Volume: 24, Issue:5
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
AID57586Compound is evaluated for the inhibition of dihydrofolate reductase from Escherichia coli1981Journal of medicinal chemistry, May, Volume: 24, Issue:5
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
AID1124510Inhibition of bovine liver dihydrofolate reductase using dihydrofolic acid as substrate1979Journal of medicinal chemistry, Jun, Volume: 22, Issue:6
Quantitative structure-activity relationship of 5-(X-benzyl)-2,4-diaminopyrimidines inhibiting bovine liver dihydrofolate reductase.
AID56785Inhibition of bovine liver Dihydrofolate reductase.1981Journal of medicinal chemistry, Jul, Volume: 24, Issue:7
Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
AID56467Inhibitory activity against chicken liver dihydrofolate reductase1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
AID56794Inhibition of bovine liver dihydrofolate reductase.1983Journal of medicinal chemistry, Jul, Volume: 26, Issue:7
Theory and application of molecular potential energy fields in molecular shape analysis: a quantitative structure--activity relationship study of 2,4-diamino-5-benzylpyrimidines as dihydrofolate reductase inhibitors.
AID26815Calculated partition coefficient (clogP)1996Journal of medicinal chemistry, Nov-22, Volume: 39, Issue:24
Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, an
AID235550Selectivity measured as log[1/Ki(Lactobacillus casei DHFR)]-log[1/Ki(chicken liver DHFR)]1998Journal of medicinal chemistry, Oct-22, Volume: 41, Issue:22
Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductase.
AID56792Inhibition of bovine liver dehydrofolate reductase.1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
AID26777Compound was evaluated for the partition coefficients probably at the pH >> 7.2 at the aqueous phase 0.1 N NaOH1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
AID57578Compound was tested for inhibition of Escherichia coli Dihydrofolate reductase.1996Journal of medicinal chemistry, Nov-22, Volume: 39, Issue:24
Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, an
AID23497Partition coefficient (logD) (aqueous phase 0.1 N HCl)1986Journal of medicinal chemistry, May, Volume: 29, Issue:5
Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysis.
AID57582In vitro inhibition of E. Coli dihydrofolate reductase.1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
AID57779Inhibitory activity against Lactobacillus casei dihydrofolate reductase1989Journal of medicinal chemistry, Aug, Volume: 32, Issue:8
On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
AID65357Inhibition of growth of methotrexate-sensitive (MB1417) strain of Escherichia coli cells.1985Journal of medicinal chemistry, Dec, Volume: 28, Issue:12
Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
AID57925Inhibitory activity against dihydrofolate reductase (DHFR) from Lactobacillus casei (expressed as log 1/Kiapp)1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-act
AID57604Binding affinity for dihydrofolate reductase from Lactobacillus casei1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Validation of EGSITE2, a mixed integer program for deducing objective site models for experimental binding data.
AID57579Inhibitory activity against Escherichia coli dihydrofolate reductase1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.
AID58159The concentration required to inhibit dihydrofolate reductase in rat liver1984Journal of medicinal chemistry, Jul, Volume: 27, Issue:7
General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.
AID57583Inhibition of dihydrofolate reductase (DHFR) from Escherichia coli.1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID56468Compound was evaluated for inhibitory activity against chicken dihydrofolate reductase1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.
AID56471Inhibitory activity against chicken dihydrofolate reductase at pH 7.2.1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A comparison of the inhibitory action of 5-(substituted-benzyl)-2,4-diaminopyrimidines on dihydrofolate reductase from chicken liver with that from bovine liver.
AID99656Inhibitory activity against murine tumor cells (L5178Y/S)1982Journal of medicinal chemistry, May, Volume: 25, Issue:5
Inhibition by 5-(substituted-benzyl)-2,4-diaminopyrimidines of murine tumor (L5178Y) cell cultures sensitive to and resistant to methotrexate. Further evidence for the sensitivity of resistant cells to hydrophobic drugs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (74.07)18.7374
1990's5 (18.52)18.2507
2000's2 (7.41)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.71 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index4.05 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]